J&J Faces Risperdal Claims For 6th Time In Philadelphia
The sixth trial in Philadelphia's Risperdal mass tort program began Friday with counsel for a Nebraska man telling a jury that the antipsychotic drug developed and manufactured by a Johnson &...To view the full article, register now.
Already a subscriber? Click here to view full article